DETAILED ACTION
This action is in response to Applicant’s submission dated February 26, 2025, in which Applicant amended claims 3, 6, 8-10, 13, 19, 25, 27, 35, 37-38, 41, and 54-56, and cancelled claims 2, 4-5, 7, 11-12, 14-18, 20-24, 26, 28-34, 36, 39-40, 42-45, and 48-53.
Information Disclosure Statement
The references contained in the IDS dated February 26, 2025 are made of record.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention.
Claims 1, 3, 25, 35, 41, 46, and 56 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Jones, et al., US 2020/0048249, which teaches the presently claimed compound for use in treating cancer in a subject harboring a PTPN11 mutation in an amount between 5 mg to 2 g per day through oral or intravenous administration. The references compounds exhibit the same activity as the compounds of the instant claims.
Claim Objections
Claims 6, 8-10, 13, 19, 27, 37-38, 47, and 54-55 are objected to as being dependent upon rejected independent claim 1, but would be allowable if rewritten in independent form including all of the limitations of the base claims and any intervening claims.
Conclusion
Any inquiry concerning this communication or earlier communications from the Examiner should be directed to ERICH A LEESER whose telephone number is (571) 272-9932. The Examiner can normally be reached Monday through Friday from 10-6 PST, M-F. PST.
If attempts to reach the Examiner by telephone are unsuccessful, the Examiner’s supervisor, Mr. James Alstrum-Acevedo can be reached at (571) 272-5548. The fax number for the organization where this application is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) toll-free at 866-217-9197. If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/ERICH A LEESER/Primary Examiner, Art Unit 1622
United States Patent and Trademark Office
Tel. No.: (571) 272-9932
Prosecution Insights